Paying Twice for the Same Pill: How Prescription Duplication Is Quietly Draining Canadian Family Budgets

For most Canadian households, prescription costs already represent a significant line item in the monthly budget. What many families do not realise is that a portion of those costs may be entirely unnecessary—the result of filling the same medication, or closely related medications, more than once without anyone noticing. This phenomenon, known as prescription duplication, is more common than provincial health authorities publicly acknowledge, and its consequences extend well beyond an inflated pharmacy receipt.

What Prescription Duplication Actually Looks Like

Prescription duplication does not always mean a patient deliberately fills the same bottle twice. In practice, it takes several forms, many of which are entirely unintentional.

The most straightforward version occurs when a patient sees two different physicians—perhaps a family doctor and a specialist—and each provider prescribes a medication from the same drug class without knowing the other has done so. A patient managing chronic pain, for example, might receive a non-steroidal anti-inflammatory drug from their rheumatologist and an overlapping prescription from their walk-in clinic physician after a separate visit. Both prescriptions may be legitimate in isolation; together, they represent a redundant and potentially harmful combination.

A second, subtler form involves therapeutic duplication—where two medications are chemically distinct but work through the same mechanism or treat the same condition. A patient prescribed both a brand-name statin and a generic version of the same drug, dispensed at different pharmacies during a transition between coverage plans, is experiencing therapeutic duplication even if the pill names look different on the label.

Finally, duplication can arise during care transitions: hospital discharge, a move between provinces, or a change in primary care provider. In each of these moments, medication lists are frequently reconstructed from memory or incomplete records, and overlaps slip through.

The Financial Toll on Canadian Families

The out-of-pocket implications are substantial. According to estimates from Canadian pharmacy benefit managers, therapeutic duplication accounts for hundreds of millions of dollars in unnecessary drug expenditure annually across the country. For individual families, the numbers can be striking. A patient unknowingly filling duplicate prescriptions for a common cardiovascular medication over the course of a year could spend anywhere from several hundred to over a thousand dollars on doses that serve no additional therapeutic purpose.

For seniors managing five or more medications—a situation affecting a significant portion of Canadians over 65—the risk of duplication compounds with each additional prescription. Many of these patients rely on a combination of provincial drug benefit programmes and private supplemental insurance, and the fragmented nature of that coverage means no single payer has a complete view of the medication list.

Why Provincial Drug Plans Struggle to Catch the Problem

One might assume that government drug benefit programmes would automatically flag duplicate claims. In reality, the oversight mechanisms vary considerably from province to province, and none of them are foolproof.

Most provincial formularies are designed to catch exact duplicates—the same drug identification number filled twice within a short window. They are far less effective at identifying therapeutic duplication across drug classes, particularly when medications are purchased at pharmacies not connected to the same adjudication network. A patient who fills one prescription at a large chain pharmacy and another at an independent community pharmacy may never trigger an alert, even if both medications accomplish the same physiological task.

Private insurers face similar limitations. Their adjudication systems are built primarily to control costs within their own plan, not to cross-reference prescriptions processed by a different insurer or paid for entirely out of pocket.

The Health Risks That Outlast the Financial Ones

Costly as duplication is, the clinical risks deserve equal attention. When two medications from the same class are taken concurrently, the risk of adverse effects typically increases without a corresponding increase in benefit. Duplicate use of blood thinners, for instance, can elevate bleeding risk to dangerous levels. Overlapping antihypertensives may cause blood pressure to drop precipitously. Two serotonergic medications taken together can, in serious cases, contribute to serotonin syndrome—a potentially life-threatening condition.

What makes these risks particularly insidious is that patients often attribute the resulting symptoms—dizziness, fatigue, gastrointestinal distress—to their underlying condition rather than to the medication overlap itself. The duplication remains invisible while the patient's quality of life quietly deteriorates.

Red Flags That Should Prompt a Medication Audit

Certain circumstances reliably increase the likelihood of prescription duplication. Patients should consider requesting a formal medication review if any of the following apply:

• Multiple prescribers: Seeing more than one physician, whether a specialist, a walk-in clinic doctor, or a nurse practitioner, without a shared electronic health record increases duplication risk considerably.
• Recent care transitions: Hospital discharge, a change in family doctor, or a provincial move are all moments when medication lists are reconstructed and errors commonly occur.
• Multiple pharmacies: Filling prescriptions at more than one dispensary—whether for convenience, price, or availability—reduces the likelihood that any single pharmacist has a complete picture of your regimen.
• Coverage changes: Switching from one drug plan to another, particularly if the transition involves a formulary change that substitutes a brand-name drug for a generic, can introduce unrecognised duplicates.
• Escalating costs without new diagnoses: If your annual prescription spending has increased without a new condition being added to your care plan, duplicate fills may be a contributing factor worth investigating.

How to Audit Your Medication List—and Who Can Help

The most effective defence against prescription duplication is a comprehensive medication review conducted by a licensed pharmacist. Unlike a physician visit, which is typically focused on diagnosis and treatment decisions, a pharmacist-led medication review is designed specifically to examine the full regimen for interactions, redundancies, and therapeutic overlaps.

To prepare for this review, gather every medication you currently take—prescription, over-the-counter, and any natural health products. Include dosage information and the name of the prescribing physician where known. If you use more than one pharmacy, request a printed dispensing history from each location before your appointment.

During the review, a licensed pharmacist can identify whether any two medications in your list belong to the same drug class, whether dosing schedules create unintended cumulative effects, and whether any prescriptions appear to have been superseded by a newer therapy without the original being formally discontinued.

At CanadaRx Health, our pharmacist consultation service is designed precisely for this purpose. Patients who access our platform benefit from a centralised medication record maintained by licensed Canadian pharmacists—meaning that regardless of how many prescribers are involved in your care, a single professional has visibility over your complete regimen. That continuity is not a luxury; for many patients managing complex conditions, it is the only reliable mechanism for catching the duplications that provincial systems routinely miss.

A Simple Step With Significant Consequences

Prescription duplication rarely announces itself. It accumulates quietly, buried in co-pay receipts and insurance statements, while the clinical consequences manifest as symptoms that seem unrelated to any medication error. The Canadian families most affected are often those already carrying the heaviest health burdens—seniors, patients with multiple chronic conditions, and individuals navigating fragmented care across multiple providers.

The good news is that the solution is neither expensive nor complicated. A single, thorough medication review with a licensed pharmacist—conducted annually or following any significant change in your health or coverage status—is sufficient to identify and eliminate the vast majority of duplicates. The investment of an hour's time can, for many families, translate into hundreds of dollars in recovered spending and a meaningfully safer medication regimen.

If you have not reviewed your complete prescription list recently, there is no better time to start.